Shop
-1.png)
eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
November 29 2025
JAMA Dermatology has recently published the results of a retrospective cohort study evaluating the efficacy of supplementation with nicotinamide, vita...
BMC Medicine recently published a post hoc analysis of the ADVANCE trial, describing the relationship between healthy lifestyle factors (HLF) and the incidence of both microvascular and macrovascular events, as well as overall mortality, among people with type 2 diabetes (T2D) and a high risk for cardiovascular disease. The ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation) trial was a 2 × 2 factorial randomized controlled trial of intense lowering of blood pressure and glucose in this population. Adults were recruited from 20 countries, with over 11,000 included in the post hoc analysis.
The 4 HLF included were smoking status, alcohol consumption, level of physical activity, and the waist-to-hip ratio (WHR), with each category receiving 1 point respectively for the following: never smoking, no more than 21 (men) or 14 (women) drinks per week, at least 15 minutes per week of moderate to vigorous exercise, and a WHR less than 0.9 (men) and 0.85 (women). Major macrovascular events (e.g., death from a cardiovascular cause, non-fatal heart attack, or stroke) and minor events (such as retinopathy, worsening renal disease, etc.) were assessed over a mean 5-year follow-up.
Participants with a higher score at baseline (3 to 4) had a 32% lower risk for major macro- or microvascular events and a 52% reduction in all-cause mortality, risk reductions which were consistent across a wide range of participants. This is a striking reduction in risk over a fairly short period of time, especially when considering the relatively low bar set for HLFs. Only 125 adults had a perfect score of 4 points, highlighting the low prevalence of healthy behaviors in this population, yet it’s plausible that a higher bar would have been associated with even greater benefits. If 15 minutes of exercise per week was beneficial, for example, perhaps substantially greater reductions in mortality would accompany more rigorous exercise goals.
Submit this form and you'll receive our latest news and updates.
Scientific Reports, one of the Nature journals, has recently published the results of a randomized clinical trial evalua...
Learn moreResults of the U.S. Diabetes Prevention Program (DPP) were first published in 2002 in the New England Journal of Medicin...
Learn moreAn analysis recently published in Cardiovascular Diabetology used a cluster-based approach to quantify the risk for deve...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
Proposition 65 Warning
© 2025 Biotics Research Corporation - All Rights Reserved
Submit your comment